Skip to main content

Fat Grafting to the Mons Pubis (Volume Restoration)

Autologous fat grafting to the mons pubis is the volume-restoration counterpart to monsplasty. It restores contour and rejuvenates the pubic mound in patients with volume depletion — from aging, massive weight loss with prior over-resection, constitutional thinness, or post-surgical deformity. The technique provides both volumetric restoration and regenerative trophic effects (neocollagenesis, neoangiogenesis, estrogen-receptor upregulation) via adipose-derived stem cells (ADSCs) within the graft.[1][2] For positioning vs other female cosmetic options see Cosmetic Genital Surgery — Female.

Society positioning

The ACOG 2020 Committee Opinion No. 795 notes that the safety and effectiveness of female genital cosmetic procedures, including mons-pubis fat grafting, have not been well documented.[3] The FIGO 2025 Statement echoes this position. Mandatory BDD screening belongs at the front of every consultation. Evidence for mons-specific fat grafting is predominantly Level IV; no universal protocol exists.

Indications​

Fat grafting to the mons addresses volume deficiency rather than excess[4][5][6][2][7][1]:

  • Age-related volume loss — natural atrophy of subcutaneous fat in the mons with aging → deflated, skeletonized appearance.[4]
  • Post–massive weight loss — concave or deflated mons after bariatric surgery or significant weight loss, sometimes after prior over-correction by liposuction or excisional monsplasty.[5][6]
  • Genitourinary syndrome of menopause (GSM) — vulvovaginal atrophy with associated dryness, dyspareunia, sexual dysfunction; fat grafting to the vulvar / mons area provides volume restoration plus regenerative trophic effects (Menkes 2021).[2]
  • Post-surgical contour deformity — concavities or irregularities after prior abdominoplasty, panniculectomy, or aggressive liposuction.[5]
  • Gender-affirming surgery — labial / mons fat grafting after penile inversion vaginoplasty to create a more natural feminine contour (Patel 2021; 83% of post-PIV fat-grafting indications).[7]
  • Aesthetic / cosmetic enhancement — improved pubic contour and fullness as part of genital beautification.[4][8]
  • Scar-tissue and pain — fat grafting can release scar contracture and reduce neuropathic pain via ADSC-mediated regeneration.[1][9]

Anatomy and volume considerations​

Seleem 2023 Aesthet Surg J provided the first comprehensive volumetric analysis of the mons pubis and labia majora[10]:

ParameterNormal BMIOverweight / obese
Mons pubis volume~ 200 mL~ 300 mL
Mons pubis weight~ 180 g~ 270 g
Labium majus volume~ 30 mL~ 40 mL
Labium majus weight~ 27 g~ 36 g

Mons height is approximately three-quarters of its length and half its width. These ratios serve as anatomic benchmarks for planning volume restoration.[10]

Surgical technique​

Harvest​

  • Donor sites: abdomen, thighs, flanks. No significant difference in fat-cell viability between sites.[9][11][12]
  • Tumescent infiltration before aspiration.[13]
  • Syringe aspiration (Toomey) or low-pressure power-assisted liposuction with 3.0–3.7 mm cannulas.[9][11]

Processing​

  • Centrifugation is the most common method and is favored over sedimentation for graft retention in clinical studies.[11]
  • Filtration and sedimentation are alternatives.
  • For genital rejuvenation, both microfat (standard structural grafting) and nanofat (mechanically emulsified, ADSC-rich) may be used — microfat for the mons / majora volume; nanofat for vaginal-mucosa trophic / regenerative effect.[2]

Injection​

  • Small-caliber blunt cannulas (0.9–2.0 mm) through stab incisions.[9][14]
  • Micro-autologous fat transplantation (MAFT) technique — small aliquots (0.05–0.1 mL per pass), multi-layer, multi-tunnel — maximizes graft-to-recipient contact and revascularization.[1]
  • Subcutaneous plane in multiple passes; small filaments deposited on each cannula withdrawal.[13][14]
  • Slower injection speed is associated with higher retention.[11]
  • Typical volumes injected into the vulva and mons range from approximately 15–30 mL, depending on the degree of volume deficit.[1]

Adjunctive strategies​

  • ADSC-assisted fat grafting showed the highest graft-survival rate (SUCRA 82.17%) compared with simple fat grafting, PRP-assisted, or SVF-assisted in the Dong 2024 network meta-analysis.[15]
  • Combined with fractional CO₂ laser for additional vulvovaginal tightening / rejuvenation as part of a comprehensive regimen (Toplu 2021).[4]

Mechanism of action​

Two complementary mechanisms[1][11][13]:

  1. Volumetric restoration. Transplanted adipocytes serve as a permanent soft-tissue filler, restoring contour and fullness.
  2. Regenerative / trophic effects. ADSCs within the graft promote neocollagenesis, neoangiogenesis, and upregulation of estrogen receptors in the recipient tissue. Lai 2023 histologic analysis after vulvovaginal fat grafting demonstrated substantially increased collagen deposition, new blood vessel formation, and ER expression, with decreased protein gene product 9.5 (associated with neuropathic pain).[1]

Outcomes​

EndpointResultReference
FSFI (sexual function)43.8 → 68.6 (p < 0.001)Lai 2023[1]
VHI (vaginal health)Significantly increased at 1 and 3 mo (p < 0.05)Menkes 2021[2]
FSD (sexual distress)Significant improvement; 80% normalized at 6 moMenkes 2021[2]
FGSIS (genital self-image)17.7 ± 1.6 → 22.2 ± 1.8 at 12 mo (p = 0.013)Cihantimur 2021 (360)[8]
Patient satisfaction94.5% satisfied / very satisfied with appearance; 80% satisfied with functional resultsToplu 2021[4]
Stable result at 18 monthsYes (microfat / nanofat for GSM)Menkes 2021[2]

Fat-graft retention​

  • General fat-transfer retention is 20–120% of injected volume, stabilizing at 60–90 days.[13]
  • Less mobile sites retain more fat.[11]
  • The mons pubis is relatively stable and well-vascularized — favorable for graft survival in principle, although site-specific retention data for the mons are limited.
  • ~ 16% of patients require at least one touch-up session.[9]

Complications​

Mons fat grafting is a low-morbidity procedure with a favorable safety profile[16][8][2]:

  • Overall complication rate for fat grafting to non-breast / non-buttock sites is 2.86% in the GRAFT registry (n = 7,052).[16]
  • Common minor complications: ecchymosis and edema at donor and recipient sites (most common, self-limited); transient tenderness in the pubic area; erythema at graft site.[8][9]
  • Rare complications: palpable mass / nodule (0.54% non-breast / non-buttock); infection (0.54%); oil cyst; fat necrosis / sclerosis (most prevalent fat-grafting complications overall); asymmetry or under- / over-correction.[16][15]
  • No cases of lipoma, granuloma formation, or serious adverse events were reported in published genital fat-grafting series.[8][2]

Fat-graft survival optimization​

FactorRecommendationReference
Donor siteNo significant difference between sitesStrong 2015; Sinno 2016[11][12]
Harvest techniqueSyringe aspiration or low-shear devices preferredStrong 2015[11]
ProcessingCentrifugation favored over sedimentation clinicallyStrong 2015[11]
Injection speedSlower injection → higher retentionStrong 2015[11]
Injection techniqueMulti-layer, multi-tunnel, small aliquotsMAFT (Lai 2023); Locke 2008[1][14]
Recipient mobilityLess mobile areas retain more fatStrong 2015[11]
TimingInject soon after harvestSinno 2016[12]
AdjunctsADSC-assisted grafting shows highest survival (SUCRA 82%)Dong 2024 NMA[15]

Fat grafting vs excisional monsplasty​

FeatureFat grafting to monsExcisional monsplasty
GoalVolume restoration / augmentationVolume reduction / lift
Typical patientVolume-depleted, atrophic mons (postmenopausal, post-bariatric over-correction)Excess fat / skin, ptotic mons (post-bariatric, obesity)
TechniqueAutologous fat injectionSkin / fat excision ± liposuction ± fascial suspension
InvasivenessMinimally invasiveModerately invasive
AnesthesiaLocal ± sedation, or generalUsually general
Recovery1–2 weeks2–4 weeks
Repeat procedures~ 16% need touch-upRarely needed

The two procedures may be combined in the same patient at different times — for example, excisional monsplasty followed by fat grafting to correct contour irregularities or prevent over-correction; or as an early-and-late solution to post-bariatric mons changes.[5]

Limitations​

  • ACOG 2020 — safety and effectiveness of cosmetic vulvar surgery, including mons fat grafting, have not been well documented.[3]
  • No universal protocol for mons-specific fat grafting; volumetric retention measurements are rarely reported for the mons.
  • No RCTs comparing fat-grafting strategies in the mons.
  • Most evidence is Level IV retrospective single-center.
  • Patients should be counseled about the unpredictability of fat-graft survival and the possible need for repeat sessions.

Postoperative management​

  • Activity restriction. Avoid intercourse, tampon use, and strenuous exercise for 2–4 weeks; protect the donor site.
  • Pressure considerations. Compression at the donor site; avoid pressure on the recipient site so as not to compress the graft.
  • Wound care. Ice 48–72 h; loose-fitting clothing.
  • Follow-up. 1 week (donor + recipient), 6 weeks, 6 months, 12 months, with FSFI / FGSIS / VHI / FSD as relevant to indication.
  • Counseling on durability and touch-ups. Up to ~ 16% may need at least one touch-up session for desired volume.

Key takeaways​

  • Fat grafting to the mons is a safe, minimally invasive procedure that provides both volumetric restoration and regenerative tissue benefits via ADSC activity.[1][2]
  • High patient satisfaction (> 90%) and significant improvements in sexual function, genital self-image, and tissue quality.[1][2][4]
  • Site-specific retention data for the mons are limited; counseling must include the possibility of touch-up.
  • Evidence base is growing but predominantly Level IV; no universal protocol for mons-specific fat grafting has been established.[11][15]
  • Optimization depends on slow injection of small aliquots in a multi-layer fashion and consideration of ADSC enrichment (highest survival on NMA).[1][15]

See Also​

References​

1. Lai YW, Wu SH, Chou PR, et al. Autologous fat grafting in female genital area improves sexual function by increasing collagenesis, angiogenesis, and estrogen receptors. Aesthet Surg J. 2023;43(8):872–884. doi:10.1093/asj/sjad040

2. Menkes S, SidAhmed-Mezi M, Meningaud JP, et al. Microfat and nanofat grafting in genital rejuvenation. Aesthet Surg J. 2021;41(9):1060–1067. doi:10.1093/asj/sjaa118

3. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. Elective female genital cosmetic surgery: ACOG Committee Opinion No. 795. Obstet Gynecol. 2020;135(1):e36–e42. doi:10.1097/AOG.0000000000003616

4. Toplu G, Altinel D. Genital beautification and rejuvenation with combined use of surgical and non-surgical methods. Aesthet Plast Surg. 2021;45(2):758–768. doi:10.1007/s00266-020-01980-z

5. Alter GJ. Pubic contouring after massive weight loss in men and women: correction of hidden penis, mons ptosis, and labia majora enlargement. Plast Reconstr Surg. 2012;130(4):936–947. doi:10.1097/PRS.0b013e318262f57d

6. Alter GJ. Management of the mons pubis and labia majora in the massive weight loss patient. Aesthet Surg J. 2009;29(5):432–442. doi:10.1016/j.asj.2009.08.015

7. Patel V, Morrison SD, Gujural D, Satterwhite T. Labial fat grafting after penile inversion vaginoplasty. Aesthet Surg J. 2021;41(3):NP55–NP64. doi:10.1093/asj/sjaa431

8. Cihantimur B, Aglamis O, Ozsular Y. 360 genital fat transfer. Aesthet Plast Surg. 2021;45(6):2996–3002. doi:10.1007/s00266-021-02488-w

9. Le JM, Bosworth JW, Honeywell B, Ananthasekar S, Collawn SS. Adipose grafting for volume and scar release. Ann Plast Surg. 2021;86(6S Suppl 5):S487–S490. doi:10.1097/SAP.0000000000002873

10. Seleem M, Osman OM, Kashmar SG, Lotfy R. Dimensions, ratios, volumes, and weights of the fatty parts of the vulva (mons pubis and labia majora). Aesthet Surg J. 2023;43(9):1002–1012. doi:10.1093/asj/sjad106

11. Strong AL, Cederna PS, Rubin JP, Coleman SR, Levi B. The current state of fat grafting: a review of harvesting, processing, and injection techniques. Plast Reconstr Surg. 2015;136(4):897–912. doi:10.1097/PRS.0000000000001590

12. Sinno S, Wilson S, Brownstone N, Levine SM. Current thoughts on fat grafting: using the evidence to determine fact or fiction. Plast Reconstr Surg. 2016;137(3):818–824. doi:10.1097/01.prs.0000479966.52477.8b

13. Fulton JE, Parastouk N. Fat grafting. Dermatol Clin. 2001;19(3):523–530, ix. doi:10.1016/s0733-8635(05)70292-8

14. Locke MB, de Chalain TM. Current practice in autologous fat transplantation: suggested clinical guidelines based on a review of recent literature. Ann Plast Surg. 2008;60(1):98–102. doi:10.1097/SAP.0b013e318038f74c

15. Dong Y, Huang Y, Hou T, Li P. Effectiveness and safety of different methods of assisted fat grafting: a network meta-analysis. Aesthet Plast Surg. 2024;48(13):2484–2499. doi:10.1007/s00266-024-04060-8

16. Kaur S, Rubin JP, Gusenoff J, et al. The General Registry of Autologous Fat Transfer: concept, design, and analysis of fat grafting complications. Plast Reconstr Surg. 2022;149(6):1118e–1129e. doi:10.1097/PRS.0000000000009162